Welcome to our dedicated page for Nitches news (Ticker: NICH), a resource for investors and traders seeking the latest updates and insights on Nitches stock.
Nitches Inc (NICH) maintains this comprehensive news hub for stakeholders tracking its dual focus on wholesale apparel distribution and cognitive wellness innovations through subsidiary InTheZone Labs. Our curated feed delivers official press releases, financial disclosures, and strategic updates from this established company with five decades of market experience.
Investors and analysts will find timely updates on quarterly earnings, private label expansions, nutraceutical product launches, and retail partnership developments. All content is sourced directly from corporate communications to ensure accuracy and compliance with financial reporting standards.
Key news categories include:
• Apparel sector updates: Wholesale agreements, licensing deals, and inventory management initiatives
• Health & wellness developments: Nootropic research breakthroughs, supplement line expansions
• Financial filings: SEC reports, dividend announcements, and capital allocation strategies
• Operational milestones: Manufacturing upgrades, quality certifications, leadership changes
Bookmark this page for streamlined access to NICH's evolving story as it bridges traditional apparel expertise with modern consumer health trends through science-backed formulations and digital-first marketing strategies.
Nitches, Inc. (OTC PINK:NICH) announces the commencement of Phase One Testing for its InTheZone Labs division's bioceutical products. The company is developing three flagship products: InTheZone Focused Extreme for mental clarity, InTheZone Passion for men's vitality, and InTheZone Youth for cognitive development in children and young adults.
The testing phase will involve three key groups: veterans and their families, medical and chiropractic experts, and former NFL players. This comprehensive approach aims to gather critical insights and refine the products for various demographics. Nitches encourages the public to visit InTheZoneLabs.com to explore and purchase these products.
The company is positioning itself to capitalize on the projected $650 billion nutraceutical and bioceutical market by 2027, offering American-made, science-backed health solutions.
Nitches, Inc. (OTC PINK:NICH) has launched InTheZone Passion, a new supplement for men's sexual health and vitality. This product aims to address declining sperm health and virility issues faced by many men due to aging and environmental stressors. Key ingredients include:
- Tribulus Terrestris for libido and sperm count
- Maca Root for fertility and energy
- L-Citrulline for blood flow and performance
- Zinc for sperm quality
- Ashwagandha (300mg) for sperm quality and testosterone
- Fenugreek Extract (500mg) for testosterone and libido
The supplement targets the growing nutraceutical market, projected to reach $650 billion by 2027. Nitches is focusing on building partnerships with distributors and affiliates to expand its reach in the men's health sector.
Nitches, Inc. (OTC PINK:NICH) has launched InTheZone Youth, a new American-made supplement designed to enhance focus and cognitive health in adolescents and young adults. This product, part of the InTheZone Labs line, aims to address concentration, memory, and decision-making challenges in school-age children, particularly those with ADHD.
Key ingredients include Omega-3 DHA, Alpha-GPC, Lion's Mane Mushroom, Bacopa Monnieri, and Astragalus Extract, each chosen for their cognitive health benefits. The supplement is manufactured in the USA in an FDA-compliant facility, adhering to Good Manufacturing Practices (GMP).
This launch represents a strategic step for Nitches in the rapidly growing nutraceutical market, projected to exceed $650 billion by 2027. The company is actively seeking to expand its affiliate and distributor network through InTheZoneLabs.com.
Nitches, Inc. (OTC PINK:NICH) has launched InTheZone Labs, a new vertical in partnership with a leading American bioceutical and nutraceutical manufacturer. This expansion introduces a range of products designed to enhance mental focus, vitality, and cognitive development. The manufacturing partner boasts certifications including GMP, FDA-audited facility standards, NSF, and ISO-90001, ensuring product safety and quality.
The flagship products include InTheZone Focused for sustained mental performance, InTheZone Passion for boosting energy and vitality, and InTheZone Focused Youth for supporting cognitive development in younger individuals. Nitches is setting up a Phase One Study led by medical experts and former NFL athletes to validate the products' effectiveness.
The company aims to capitalize on the projected $650 billion nutraceutical and bioceutical market by 2027. Nitches is building a distribution and affiliate network, inviting professionals to join through their website at InTheZoneLabs.com.
Nitches, Inc. (OTC:NICH) announces the launch of a new website and premium bioceutical product line on Wednesday. The company has partnered with a respected American-based manufacturing facility known for high safety and quality standards. The product line focuses on mental focus, vitality, and youth cognitive development, addressing pressing health challenges. Key features include:
1. Mental Focus and Cognitive Support for professionals, students, and athletes
2. Vitality and Energy formulation for improved mood and physical well-being
3. Youth Cognitive Development support for academic and extracurricular excellence
The products are Made in the USA, adhering to Good Manufacturing Practices (GMP) and FDA guidelines. Nitches aims to set a new standard in the bioceutical industry with this launch, emphasizing American craftsmanship and quality.
Nitches, Inc. (OTC Pink:NICH) is set to launch a revolutionary science-based bioceutical product line in October 2024. The company has developed three meticulously formulated products in collaboration with top-tier scientists, doctors, and FDA-approved manufacturing facilities. These products are designed to enhance human performance and well-being for both teenagers and adults.
Key highlights of the upcoming launch include:
- Revolutionary formulations backed by robust scientific research
- Uncompromising quality with manufacturing in FDA-registered facilities under cGMP guidelines
- Global impact potential to meet diverse consumer needs
Nitches ensures product quality through adherence to FDA 21 CFR 111, NSF, and ISO-90001 certifications. The company is in the final stages of discovery and formulation, with detailed product information to be revealed in the coming weeks.
Nitches Inc. (OTC PINK:NICH) has announced the formation of a new subsidiary, 'In The Zone Labs', marking its expansion into the bioceutical and pharmaceutical markets. This strategic move aims to develop innovative health and wellness products for men's and women's health sectors. The new subsidiary will focus on creating solutions that address various health concerns and enhance consumers' quality of life.
Key highlights include:
- Official incorporation of the new subsidiary
- Product focus on men's and women's health and overall wellness
- Emphasis on natural and scientifically-backed ingredients
- Collaboration with leading scientists and health professionals
Nitches Inc. (OTC PINK:NICH) celebrated a successful participation in the ALSD Conference, featuring the soft launch of Tover Spirits' Ready-To-Drink (RTD) Blood Orange Old Fashioned. The event showcased Tover Spirits to elite executives from ALSD, premium suite directors, and food and beverage purchasers from various sports teams. The product received positive feedback, with potential customers expressing interest in carrying Tover Spirits.
Nitches also introduced scent branding machines from Noryan and displayed premium stadium staff clothing, both of which were well-received. The company is preparing for Tover Spirits' full launch, with online sales expected to start in time for SOND. This success at the ALSD Conference indicates promising prospects for Tover Spirits and Nitches' innovative offerings in the market.
